Tech Company Financing Transactions

Cequent Pharmaceuticals Funding Round

Cequent Pharmaceuticals closed a $2.7 million funding round on 12/31/2009. Investors included Amidzad Partners, New England Partners and Novartis Venture Fund.

Transaction Overview

Announced On
Transaction Type
Venture Equity

Amidzad Partners (Chiang Li)

New England Partners (Thomas Hancock)

Novartis Venture Fund (Lauren Silverman)

Pappas Ventures (Eric Linsley)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Mailing Address
1 Kendall Sq. Building 700 First Floor
Cambridge, MA 02139
Email Address
Cequent Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of products to treat gastrointestinal diseases, including familial polyposis, inflammatory bowel disease and colon cancer.
Cequent Pharmaceuticals LinkedIn Company Profile
Social Media
Cequent Pharmaceuticals Company Twitter Account
Company News
Cequent Pharmaceuticals News
Cequent Pharmaceuticals on Facebook
Cequent Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Peter Parker
  Peter Parker LinkedIn Profile  Peter Parker Twitter Account  Peter Parker News  Peter Parker on Facebook
Chief Financial Officer
Lisa Velardo
  Lisa Velardo LinkedIn Profile  Lisa Velardo Twitter Account  Lisa Velardo News  Lisa Velardo on Facebook
VP - Bus. Development
Susie Truong
   Susie Truong LinkedIn Profile   Susie Truong Twitter Account   Susie Truong News   Susie Truong on Facebook
VP - R & D
Johannes Fruehauf
  Johannes Fruehauf LinkedIn Profile  Johannes Fruehauf Twitter Account  Johannes Fruehauf News  Johannes Fruehauf on Facebook
VP - Regulatory Affairs
Pamela Fekete
  Pamela Fekete LinkedIn Profile  Pamela Fekete Twitter Account  Pamela Fekete News  Pamela Fekete on Facebook



Browse more venture capital transactions:

Prev: 12/31/2009: Calistoga Pharmaceuticals venture capital transaction
Next: 12/31/2009: AtheroMed venture capital transaction


Share this article


About Database of VC Transactions

Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary